Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial
- Resource Type
- Article
- Authors
- Shi, Lei; Yuan, Xin; Yao, Weiqi; Wang, Siyu; Zhang, Chao; Zhang, Bo; Song, Jinwen; Huang, Lei; Xu, Zhe; Fu, Jun-Liang; Li, Yuanyuan; Xu, Ruonan; Li, Tian-Tian; Dong, Jinghui; Cai, Jianming; Li, Genshi; Xie, Yunbo; Shi, Ming; Li, Yonggang; Zhang, Yu; Xie, Wei-Fen; Wang, Fu-Sheng
- Source
- In eBioMedicine January 2022 75
- Subject
- Language
- ISSN
- 2352-3964